| ¿µ¹® | hyperplasia | ÇÑ±Û | °ú´ÙÇü¼º, Áõ½Ä |
|---|---|---|---|
| ¼³¸í | ±â´ÉÇ×ÁøÀ» À¯¹ß½ÃŰ´Â ÀÚ±ØÀ» ¹Þ¾ÒÀ» ¶§ ºÐ¿ÀÌ °¡´ÉÇÑ ¼¼Æ÷°¡ ¼¼Æ÷ºÐ¿·Î ±× ¼ö°¡ Áõ°¡µÇ´Â °ÍÀ» Áõ½ÄÀ̶ó Çϸç, °á°úÀûÀ¸·Î ±× Á¶Á÷À̳ª Àå±âµµ Ä¿Áö°Ô µÈ´Ù. ºñ´ë´Â ´Ü¼øÈ÷ ¼¼Æ÷ÀÇ Áõ½ÄÀÌ ¾øÀÌ ¼¼Æ÷ÀÇ Å©±â°¡ Ä¿Áö´Â °æ¿ì¸¦ À̸£´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | adrenal gland | ÇÑ±Û | ºÎ½Å |
|---|---|---|---|
| ¼³¸í | ÄáÆÏÀ§¿¡ Á¸ÀçÇÏ´Â ÇǶó¹Ô¸ð¾çÀÇ ±¸Á¶¹°. °ÑÁú°ú ¼ÓÁú·Î µÇ¾î ÀÖÀ¸¸ç È£¸£¸óÀÇ ºÐºñ°¡ ÁÖ¿ªÇÒÀÌ´Ù. ![]() |
||
| ¿µ¹® | adrenal medulla | ÇÑ±Û | ºÎ½Å¼ÓÁú |
|---|---|---|---|
| ¼³¸í | ºÎ½ÅÀÇ ¾ÈÂÊ¿¡ ÀÖ´Â ºÎºÐÀ¸·Î ºÎ±³°¨½Å°æÀÇ Áö¹è¸¦ ¹Þ¾Æ¼ Ä«Å×Äݶó¹Î(catecholamine)À» ºÐºñÇÑ´Ù. |
||
| ¿µ¹® | Benign Prostatic Hyperplasia(BPH) | ÇÑ±Û | Àü¸³»ùºñ´ë |
|---|---|---|---|
| ¼³¸í | 50¼¼ ÀÌ»óÀÇ ³²¼º¿¡ ºó¹ßÇÏ´Â º´À¸·Î Àü¸³»ùÀÇ ¿äµµ ÁÖÀ§ ¿µ¿ª¿¡ Å«°áÀýÀ» Çü¼ºÇÏ¿©, À̰ÍÀÌ Ä¿Áö¸é ¿äµµ¸¦ ¾Ð¹ÚÇÏ¿© ºÎºÐÀû ȤÀº ¿ÏÀüÇÑ ¿äµµÆó»öÀ» ÀÏÀ¸Å°´Â º´ÀÌ´Ù. Áõ»óÀº ¿äµµÆó»ö¿¡ µû¸¥ ¼Òº¯ÀÇ °¨¼Ò¿Í ¹æ±¤ÀÚ±ØÁõ»óÀ¸·Î ºó´¢, ÀÜ´¢°¨, ¼Òº¯À» ÂüÀ» ¼ö ¾ø´Â Áõ»ó µîÀÌ´Ù. Ä¡·á´Â °æ¿äµµ Àü¸³»ù ÀûÃâ¼ú·Î Àü¸³¼±ÀÇ ºñ´ëÇÑ ºÎºÐÀ» ÀýÁ¦ÇØ¾ß ÇÑ´Ù. |
||
| CAH | 1) Chronic Active Hepatitis 2) Congenital Adrenal Hyperplasia |
|---|---|
| CAH | chronic active hepatitis; chronic aggressive hepatitis; combined atrial hypertrophy; congenital adre... |
| CLAH | congenital lipoid adrenal hyperplasia |
| CVAH | congenital virilizing adrenal hyperplasia |
| IAH | idiopathic adrenal hyperplasia; implantable artificial heart |
| CAH | Cogenital adrenal hyperplasia |
|---|---|
| lipoid CAH | lipoid adrenal hyperplasia |
| AAS | Anabolic androgenic steroid |
| AAS | Androgenic anabolic steroids |
| AA | Adrenal androgen |
| adrenal hyperplasia | <pathology> A condition of diffuse enlargement of the adrenal glands. Origin: Gr. Plassein = to form (27 Sep 1997) |
|---|---|
| adrenal hyperplasia, congenital | A group of inherited disorders of adrenal steroidogenesis, the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect, and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form, and a 3-beta-hydroxysteroid deficiency form. (12 Dec 1998) |
| congenital adrenal hyperplasia | <endocrinology> A genetic disorder present at birth characterised by a deficiency of the hormones aldosterone and cortisol and an overproduction of male sex hormones (androgens). In males this may manifest as enlarged penis, small testes and early development of masculine characteristics. In females features include ambiguous genitalia, failure to menstruate, deep voice and excessive hair. Origin: Gr. Plassein = to form (27 Sep 1997) |
| congenital virilizing adrenal hyperplasia | A series of inherited inborn errors of metabolism with hyperplasia of the adrenal cortex and overproduction of virilizing hormones. Most common forms are due to partial or complete 21-hydroxylase deficiency, leading to increased ACTH production by the pituitary, stimulating adrenal growth and function. Severe form is characterised by salt-losing state. (05 Mar 2000) |
| androgenic | <embryology, pharmacology> Producing masculine characteristics. Origin: Gr. Gennan = to produce (18 Nov 1997) |
| androgenic alopecia | Hair loss in women that may be associated with aging, hormones (androgens) or genetic predisposition. The pattern of baldness in women is different from that of men. In women there is thinning of the hair all over the scalp, but the frontal hairline is maintained. The hair loss is usually permanent. Treatment has been successful with topical minoxidil in some cases. (27 Sep 1997) |
| androgenic hormone | <endocrinology> A male (masculinising) hormone. These medications (testosterone, methyltestosterone, fluoxymesterone, danazol) are used to treat androgen deficiency, delayed puberty in males and some forms of breast cancer. (27 Sep 1997) |
| androgenic zone | A transient adrenocortical zone present in some rodents at birth, most notably in mice, situated between the zona reticularis and the adrenal medulla; it degenerates in males with the secretion at puberty and in females during their first pregnancy; it slowly enlarges in unmated females after puberty and does not degenerate until middle age; the X zone appears to secrete no hormone. Synonym: androgenic zone. Misnomer for the foetal adrenal cortex of primates. Synonym: foetal reticularis. (05 Mar 2000) |
| hormone, androgenic | Any hormone that promotes the development and maintenance of male sex characteristics. Testosterone is an androgen. (12 Dec 1998) |
| angiofollicular mediastinal lymph node hyperplasia | Solitary masses of lymphoid tissue containing concentric perivascular aggregates of lymphocytes, occurring usually in the mediastinum or hilar region of young adults; similar changes have been reported outside the mediastinum and, if associated with interfollicular sheets of plasma cells, may progress to lymphoma or plasmacytoma. Synonym: angiofollicular mediastinal lymph node hyperplasia, Castleman's disease. (05 Mar 2000) |
| angiolymphoid hyperplasia with eosinophilia | Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells. (12 Dec 1998) |
| atypical melanocytic hyperplasia | Proliferation of melanocytes showing nuclear atypicality, especially as scattered single cells high in the epidermis; interpreted by some pathologists as malignant melanoma in situ. (05 Mar 2000) |
| basal cell hyperplasia | Increase in the number of cells in an epithelium resembling the basal cells. (05 Mar 2000) |
| benign giant lymph node hyperplasia | Solitary masses of lymphoid tissue containing concentric perivascular aggregates of lymphocytes, occurring usually in the mediastinum or hilar region of young adults; similar changes have been reported outside the mediastinum and, if associated with interfollicular sheets of plasma cells, may progress to lymphoma or plasmacytoma. Synonym: angiofollicular mediastinal lymph node hyperplasia, Castleman's disease. (05 Mar 2000) |
| benign prostatic hyperplasia | <urology> A benign enlargement of the prostate gland begins normally after age 50 years probably secondary to the effects of male hormones. If significant enlargement occurs, it may pinch off te urethra making urination difficult or impossible. See: urinary retention. Origin: Gr. Plassein = to form (06 Aug 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|